THC and CBD offer therapeutic potential in the treatment of bipolar affective disorder (BAD), sharing characteristics with medications known to be effective for the disorder such as antidepressants, antipsychotics, mood stabilizers (anticonvulsants), and anxiolytics. The available evidence highlights the importance of precise administration methods and dosage control when using these cannabinoids.